Enzyme Safely Starves Cancer Cells in Preclinical Study

A research team led by scientists at The University of Texas Austin has engineered an enzyme that safely treats prostate and breast cancer in animals and also lengthens the lifespan of models that develop chronic lymphocytic leukemia. The new treatment and results from preclinical trials are described in a paper published in the Nov. 21 issue of Nature Medicine.


Leave a Reply

Your email address will not be published. Required fields are marked *